Stoke Therapeutics, Inc. (STOK)
35.50
+0.85
(+2.45%)
USD |
NASDAQ |
Mar 06, 16:00
35.50
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Cash from Investing (TTM) : -124.93M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Biogen, Inc. | -1.371B |
| Krystal Biotech, Inc. | -58.42M |
| Scholar Rock Holding Corp. | 218.69M |
| Zymeworks, Inc. | 26.72M |
| Moderna, Inc. | 1.946B |